| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/02/2004 | EP1372698A2 Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders |
| 01/02/2004 | EP1372688A2 Somatostatin antagonists |
| 01/02/2004 | EP1372665A2 Hormone replacement therapy method and its administration form |
| 01/02/2004 | EP1372660A2 A combination of fbpase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 01/02/2004 | EP1372646A2 Use of sugar phosphates, sugar phosphate analogues, amino acids, amino acid analoges for modulating transaminases and/or the association of p36/malate dehydrogenase |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1372618A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 01/02/2004 | EP1250146B1 Use of botulinum toxins for treating diabetes |
| 01/02/2004 | EP1203011B1 Orally active androgens |
| 01/01/2004 | US20040002535 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002519 Mixture of hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, insulin elimination promoter and insulin sensitizer with carrier |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002482 Androgen pharmaceutical composition and method for treating depression |
| 01/01/2004 | US20040002468 Methods of treating diabetes and other blood sugar disorders |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040001895 Combination treatment for depression and anxiety |
| 01/01/2004 | US20040001815 Dietary supplements for regulating male hormone |
| 12/31/2003 | WO2004001020A2 Methods and means to promote gut absorption |
| 12/31/2003 | WO2004000869A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 12/31/2003 | WO2004000845A1 Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | WO2004000805A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof |
| 12/31/2003 | WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 12/31/2003 | WO2004000801A2 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 12/31/2003 | WO2004000790A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 12/31/2003 | WO2004000785A2 Phenyloxyalkanonic acid derivatives as hppar activators |
| 12/31/2003 | WO2004000361A1 Metastable pharmaceutical compositions |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000230A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 12/31/2003 | WO2004000225A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 12/31/2003 | WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 12/31/2003 | WO2003080021A3 Formulation comprising buprenorphine |
| 12/31/2003 | WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo |
| 12/31/2003 | WO2003059269A3 Acridone inhibitors of impdh enzyme |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002043750A8 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations |
| 12/31/2003 | WO2002043578A3 Determination of risk and treatment of complications of prematurity |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | WO2001006984A3 Small molecules useful in the treatment of inflammatory disease |
| 12/31/2003 | CN1464791A Compositions for protein delivery via the pulmonary route |
| 12/31/2003 | CN1464787A Novel hormone composition |
| 12/31/2003 | CN1132845C Improved method for obtaining isulin precursor having correctly-bonded cystine bond |
| 12/31/2003 | CN1132626C Stabilised growth hormone formulation and method of preparation thereof |
| 12/31/2003 | CA2490112A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof |
| 12/31/2003 | CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 12/31/2003 | CA2490057A1 Metastable pharmaceutical compositions |
| 12/31/2003 | CA2489930A1 Methods and means to promote gut absorption |
| 12/31/2003 | CA2489847A1 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 12/31/2003 | CA2489815A1 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 12/31/2003 | CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 12/31/2003 | CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/30/2003 | US6670493 Methods and compositions for treating diseases due to androgen deficiency with glucocorticoid receptor antagonist compounds and new compounds |
| 12/30/2003 | US6670380 Pyridone inhibitors of fatty acid binding protein and method |
| 12/30/2003 | US6670353 Oxime-group containing oestrone sulphatase inhibitors |
| 12/30/2003 | US6670352 Androgenic steroid compounds and a method of making and using the same |
| 12/30/2003 | US6670350 Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same |
| 12/30/2003 | US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties |
| 12/30/2003 | CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists |
| 12/29/2003 | WO2004002469A1 Isoflavone concentrate and method for production thereof |
| 12/29/2003 | CA2448513A1 Isoflavone concentrates, as well as methods for their production |
| 12/25/2003 | US20030237101 Stem cell factor; modulation of gene expression |
| 12/25/2003 | US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors |
| 12/25/2003 | US20030236389 Proteins, polynucleotides encoding them and methods of using the same |
| 12/25/2003 | US20030236295 Tricylic indole compounds having affinity for serotonin receptor |
| 12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 12/25/2003 | US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal |
| 12/25/2003 | US20030235609 Use of cholinesterase antagonists to treat insulin resistance |
| 12/25/2003 | US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation |
| 12/25/2003 | US20030235536 Administering an aerosol, a conjugate of a therapeutic agent and an FcRn binding partner, for treating resipiratory system disorders, drug delivery of an antibody, immunizing vaccines |
| 12/24/2003 | WO2003106452A2 Antagonists of melanin concentrating hormone receptor |
| 12/24/2003 | WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | WO2003106441A1 Pharmaceutical salts of reboxetine |
| 12/24/2003 | WO2003106411A1 24-sulfoximine vitamin d3 compounds |
| 12/24/2003 | WO2003106410A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 12/24/2003 | WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | WO2003105893A2 Probiotic therapies |
| 12/24/2003 | WO2003105834A1 Bazedoxifene treatment regimens |
| 12/24/2003 | WO2003105815A1 Combination of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 12/24/2003 | WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein |
| 12/24/2003 | WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 12/24/2003 | WO2003032963A3 Method of reducing type 2 diabetes in high risk patients |
| 12/24/2003 | WO2002102321A3 Novel proteins and nucleic acids encoding same |
| 12/24/2003 | WO2002046147A3 Perturbed membrane-binding compounds |
| 12/24/2003 | WO2002034204A8 Calcilytic compounds |
| 12/24/2003 | CA2489791A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of anxiety or depression |
| 12/24/2003 | CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament |
| 12/24/2003 | CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | CA2489098A1 Bazedoxifene treatment regimens |
| 12/24/2003 | CA2488643A1 Coated particles, methods of making and using |
| 12/23/2003 | US6667313 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators |
| 12/18/2003 | WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |